Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2021 Apr 19;20(1):34.
doi: 10.1186/s12944-021-01463-3.

Regulation of circulating CTRP-2/CTRP-9 and GDF-8/GDF-15 by intralipids and insulin in healthy control and polycystic ovary syndrome women following chronic exercise training

Affiliations
Clinical Trial

Regulation of circulating CTRP-2/CTRP-9 and GDF-8/GDF-15 by intralipids and insulin in healthy control and polycystic ovary syndrome women following chronic exercise training

Jayakumar Jerobin et al. Lipids Health Dis. .

Abstract

Background: Polycystic ovary syndrome (PCOS) is associated with obesity, diabetes, and insulin resistance. The circulating C1Q/TNF-related proteins (CTRP-2, CTRP-9) and growth differentiation factors (GDF-8, GDF-15) contribute to glucose and lipid homeostasis. The effects of intralipids and insulin infusion on CTRP-2, CTRP-9, GDF-8 and GDF-15 in PCOS and control subjects before and after chronic exercise training were examined.

Methods: Ten PCOS and nine healthy subjects were studied at baseline status and after moderate-intensity chronic exercise training (1 h exercise, 3 times per week, 8 weeks). All participants were infused with 1.5 mL/min of saline or intralipids (20%) for 5 h, and during the last 2 h of saline or intralipids infusion hyperinsulinemic-euglycemic clamp (HIEC) was performed. CTRP-2, CTRP-9, GDF-8 and GDF-15 levels were measured at 0, 3 and 5 h.

Results: Intralipids dramatically increased CTRP-2 levels in PCOS (P = 0.02) and control (P = 0.004) subjects, which was not affected by insulin infusion or by exercise. Intralipids alone had no effects on CTRP-9, GDF-8, or GDF-15. Insulin increased the levels of GDF-15 in control subjects (P = 0.05) during the saline study and in PCOS subjects (P = 0.04) during the intralipid infusion. Insulin suppressed CTRP9 levels during the intralipid study in both PCOS (P = 0.04) and control (P = 0.01) subjects. Exercise significantly reduced fasting GDF-8 levels in PCOS (P = 0.03) and control (P = 0.04) subjects; however, intralipids infusion after chronic exercise training increased GDF-8 levels in both PCOS (P = 0.003) and control (P = 0.05) subjects and insulin infusion during intralipid infusion reduced the rise of GDF-8 levels.

Conclusion: This study showed that exogenous lipids modulate CTRP-2, which might have a physiological role in lipid metabolism. Since chronic exercise training reduced fasting GDF-8 levels; GDF-8 might have a role in humoral adaptation to exercise. GDF-15 and CTRP-9 levels are responsive to insulin, and thus they may play a role in insulin responses.

Keywords: C1Q/TNF related proteins; Euglycemic clamp; Exercise and polycystic ovary syndrome; Growth differentiation factors; Insulin; Insulin resistance; Lipid.

PubMed Disclaimer

Conflict of interest statement

No competing interest declared by the authors.

Figures

Fig. 1
Fig. 1
Overall schematic representation of the study. Saline-HIEC and the following week Intralipid-HIEC clamp were performed. All the study participants umderwent eight weeks of chronic exercises training. Following this Saline-HIEC and the following week Intralipid-HIEC clamp were performed to assess the effect of exercise on insulin sensitivity
Fig. 2
Fig. 2
CTRP2, CTRP9,GDF-8 and GDF-15 levels in healthy controls and PCOS women. a CTRP-2; b CTRP-9; c GDF-8; d GDF-15. P < 0.05 is found to be statistically significant. No significant differences in CTRP-2, CTRP-9, GDF-8 and GDF-15 levels were observed between control and PCOS women. Student’s unpaired t-test was done to determine the significance between the control and PCOS subjects

Similar articles

Cited by

References

    1. Sam S. Obesity and polycystic ovary syndrome. Obes Manag. 2007;3(2):69–73. doi: 10.1089/obe.2007.0019. - DOI - PMC - PubMed
    1. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1–13. doi: 10.2147/CLEP.S37559. - DOI - PMC - PubMed
    1. Goyal M, Dawood AS. Debates regarding lean patients with polycystic ovary syndrome: a narrative review. J Hum Reprod Sci. 2017;10(3):154–161. doi: 10.4103/jhrs.JHRS_77_17. - DOI - PMC - PubMed
    1. Faloia E, Canibus P, Gatti C, Frezza F, Santangelo M, Garrapa GGM, Boscaro M. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Investig. 2004;27(5):424–429. doi: 10.1007/BF03345285. - DOI - PubMed
    1. Akshaya S, Bhattacharya R. Comparative study of clinical profile of lean and obese polycystic ovary syndrome women. Int J Reprod Contracept Obstet Gynecol. 2017;5:4.

Publication types